U.S. markets open in 4 hours
  • S&P Futures

    3,315.50
    +28.25 (+0.86%)
     
  • Dow Futures

    27,279.00
    +236.00 (+0.87%)
     
  • Nasdaq Futures

    11,268.00
    +131.50 (+1.18%)
     
  • Russell 2000 Futures

    1,482.50
    +15.30 (+1.04%)
     
  • Crude Oil

    39.89
    -0.36 (-0.89%)
     
  • Gold

    1,856.30
    -10.00 (-0.54%)
     
  • Silver

    22.82
    -0.27 (-1.18%)
     
  • EUR/USD

    1.1650
    +0.0015 (+0.13%)
     
  • 10-Yr Bond

    0.6590
    0.0000 (0.00%)
     
  • Vix

    27.02
    -1.49 (-5.23%)
     
  • GBP/USD

    1.2848
    +0.0103 (+0.81%)
     
  • USD/JPY

    105.3270
    -0.2190 (-0.21%)
     
  • BTC-USD

    10,875.39
    +96.58 (+0.90%)
     
  • CMC Crypto 200

    223.66
    +5.83 (+2.68%)
     
  • FTSE 100

    5,908.82
    +66.15 (+1.13%)
     
  • Nikkei 225

    23,511.62
    +307.00 (+1.32%)
     

Thermo Fisher Scientific (TMO) Stock Moves -0.28%: What You Should Know

Zacks Equity Research

Thermo Fisher Scientific (TMO) closed the most recent trading day at $433.88, moving -0.28% from the previous trading session. This move was narrower than the S&P 500's daily loss of 0.46%. Elsewhere, the Dow gained 0.13%, while the tech-heavy Nasdaq lost 1.25%.

Prior to today's trading, shares of the maker of scientific instrument and laboratory supplies had gained 4.27% over the past month. This has outpaced the Medical sector's gain of 0.49% and the S&P 500's gain of 1% in that time.

Investors will be hoping for strength from TMO as it approaches its next earnings release. The company is expected to report EPS of $4.27, up 45.24% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $7.54 billion, up 20.15% from the prior-year quarter.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $15.78 per share and revenue of $28.74 billion. These totals would mark changes of +27.77% and +12.53%, respectively, from last year.

It is also important to note the recent changes to analyst estimates for TMO. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 3.89% higher within the past month. TMO is currently a Zacks Rank #1 (Strong Buy).

Valuation is also important, so investors should note that TMO has a Forward P/E ratio of 27.57 right now. Its industry sports an average Forward P/E of 48.45, so we one might conclude that TMO is trading at a discount comparatively.

Also, we should mention that TMO has a PEG ratio of 1.78. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. TMO's industry had an average PEG ratio of 3.91 as of yesterday's close.

The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 182, putting it in the bottom 29% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow TMO in the coming trading sessions, be sure to utilize Zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research